N-trimethyl chitosan chloride-coated liposomes for the oral delivery of curcumin

Journal of Liposome Research

Volumn 22, Issue 2, 2012, Pages 100-109

  Chen, Huanlei ^a   Wu, Jun ^b   Sun, Min ^a   Guo, Chenyu ^a   Yu, Aihua ^a   Cao, Fengliang ^a   Zhao, Liyan ^a   Tan, Qi ^a   Zhai, Guangxi ^a  

^a SHANDONG UNIVERSITY   (China)

^b University of South Carolina   (United States)

Author keywords

Curcumin; Liposomes; N trimethyl chitosan chloride; Oral delivery

Indexed keywords

CHOLESTEROL; CURCUMIN; LIPOSOME; N TRIMETHYL CHITOSAN CHLORIDE COATED LIPOSOME; TOCOFERSOLAN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DISPERSION; DRUG BIOAVAILABILITY; DRUG COATING; DRUG FORMULATION; ENCAPSULATION; IN VITRO STUDY; IN VIVO STUDY; INFRARED SPECTROSCOPY; NONHUMAN; PHARMACOLOGICAL PARAMETERS; PRIORITY JOURNAL; PROCESS OPTIMIZATION; PROTON NUCLEAR MAGNETIC RESONANCE; RAT; SOYBEAN;

ADMINISTRATION, ORAL; ANIMALS; BIOLOGICAL AVAILABILITY; CHITOSAN; CURCUMIN; DRUG CARRIERS; LIPOSOMES; MOLECULAR STRUCTURE; RATS;

EID: 84862084129     PISSN: 08982104     EISSN: 15322394     Source Type: Journal    
DOI: 10.3109/08982104.2011.621127     Document Type: Article

References (74)

1. Aggarwal, B. B., Shishodia, S. (2006). Molecular targets of dietary agents for prevention and therapy of cancer. Biochem Pharmacol 71: 1397-1321.
2. Alamelu, S., Rao, K. P. (1991). Studies on the carboxymethyl chitosancontaining liposomes for their stability and controlled release of dapsone. J Microencapsul 8: 505-519.
3. Araujo, C. C., Leon, L. L. (2001). Biological activities of Curcuma longa L. Mem Inst Oswaldo Cruz 96: 723-728. (Pubitemid 33704182)
4. Avgoustakis, K., Beletsi, A., Panagi, Z. (2002). PLGA-mPEG nanoparticles of cisplatin: in vitro nanoparticle degradation, in vitro drug release, and in vivo drug residence in blood properties. J Contr Rel 79: 123-135. (Pubitemid 34164166)
5. Bakshi, M. S., Kaur, N., Mahajan, R. K. (2006). A comparative behavior of photophysical properties of Pluronic F127 and Triton X-100 with conventional zwitterionic and anionic surfactants. J Photochem Photobio A Chem 183: 146-153.
6. Cao, J., Sun, J. K., Wang, X. Y., Li, X. R., Deng, Y. J. (2009). N-Trimethyl chitosan-coated multivesicular liposomes for oxymatrine oral delivery. Drug Dev Ind Pharm 35: 1339-1347.
7. Cao, N., Feng, S. S. (2008). Doxorubicin conjugated to D-a-tocopheryl polyethylene glycol 1000 succinate (TPGS): conjugation chemistry, characterization, and in vitro and in vivo evaluation. Biomaterials 29: 3856-3865
8. Charles R. M., Calvin, M. (1971). Use of high-performance swingingbucket rotors for micro preparative centrifugation. Anal Biochem 44: 235-238.
9. Cheng, A. L., Hsu, C. H., Lin, J. K., Hsu, M. M., Ho, Y. F., Shen, T. S., et al. (2001). Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res 21: 2895-2900
10. Das, R. K., Kasoju, N., Bora, U. (2010). Encapsulation of curcumin in alginate-chitosan-pluronic composite nanoparticles for delivery to cancer cells. Nanomedicine 6: 153-160.
11. Dintaman, J. M., Silverman, J. A. (1999). Inhibition of P-glycoprotein by D-alpha-tocopheryl polyethylene glycol 1000 succinate (TPGS). Pharm Res 16: 1550-1556. (Pubitemid 29510551)
12. Dong, C., Rogers, J. A. (1991). Quantitative determination of carboxymethyl chitin in polymer-coated liposomes. J Microencapsul 8: 153-160.
13. Drummond, D., Meyer, O., Hong, K., Kirpotin, D., Papahadjopoulos, D. (1999). Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors. Pharmacol Rev 51: 691-643.
14. Eliaz, R. E., Nir, S., Marty, C., Szoka, F. (2004). Determination and modeling of kinetics of cancer cell killing by doxorubicin and doxorubicin encapsulated in targeted liposomes. Cancer Res 64: 711-718. (Pubitemid 38120914)
15. Filipovic-Grcic, J., Skalko-Basnet, N., Jalsenjal, I. (2001). Mucoadhesive chitosan-coated liposomes: characteristics and stability. J Microencapsul 18: 3-12. (Pubitemid 32058676)
16. Gao, Y., Li, L. B., Zhai, G. X. (2008). Preparation and characterization of Pluronic/TPGS mixed micelles for solubilization of camptothecin. Colloid Surf B Biointerf 64: 194-199.
17. Hamman, J. H., Stander, M., Kotze, A. F. (2002). Effect of the degree of quaternisation of N-trimethyl chitosan chloride on absorption enhancement: in vivo evaluation in rat nasal epithelia. Int J Pharm 232: 235-242. (Pubitemid 34076769)
18. Hsu, C. H., Cheng, A. L. (2007). Clinical studieswith curcumin. Adv Exp Med Biol 595: 471-480.
19. Huo, D. J., Deng, S. H., Li, L. B., Ji, J. B. (2005). Studies on the poly (lactic-coglycolic) acid microspheres of cisplatin for lung-targeting. Int J Pharm 289: 63-67.
20. Iwanaga, K., Ono, S., Narioka, K., Morimoto, K., Kakemi, M., Yamashita, S., et al. (1997). Oral delivery of insulin by using surface coating liposomes: improvement of stability of insulin in GI tract. Int J Pharm 157: 73-80. (Pubitemid 27432583)
21. Johnson, J. J., Mukhtar, H. (2007). Curcumin for chemopreventive of colon cancer, Cancer Lett 255: 170-181.
22. Koshkina, N. V., Waldrep, J. C., Roberts, L. E., Golunski, E., Melton, S., Knight, V. (2001). Paclitaxel liposome aerosol treatment induces inhibition of pulmonary metastases in murine renal carcinoma model. Clin Cancer Res 7: 3258-3262. (Pubitemid 32963851)
23. Lao, C., Ruf?n, M., Normolle, D., Health, D., Murray, S., Bailey, J. (2006). Dose escalation of curcuminoid formulation. BMC Complement Altern Med 6: 10-15.
24. Li, J., Jiang, Y. Y., Fan, G. R., Wu, Y. T., Zhang, C. (2009a). A rapid and simple HLPC method for the determination of curcumin in rat plasma: assay development, validation, and application to a pharmacokinetic study of curcumin liposome. J Biomed Chromatogr 23: 1201-1207.
25. Li, N., Zhuang, C. Y., Sun, X. Y., Nie, S. F., Pan, W. S. (2009b). Liposome coated with low molecular weight chitosan and its potential use in ocular drug delivery. Int J Pharm 379: 131-138.
26. Maiti, K., Mukherjee, K., Gantait, A., Saha, B. P., Mukherjee, P. K. (2007). Curcumin-phospholipid complex: preparation, therapeutic evaluation, and pharmacokinetic study in rats. Int J Pharm 330: 155-163. (Pubitemid 46097368)
27. Marczylo, T. H., Verschoyle, R. D., Cooke, D. N., Morazzoni, P., Steward, W. P., Gescher, A. J. (2007). Comparison of systemic availability of curcumin with that of curcumin formulated with phosphatidylcholine. Cancer Chemother Pharm 60: 171-177. (Pubitemid 46742531)
28. Mady, M. M., Darwish, M. M., Khalil, S., Khalil, W. M. (2009). Biophysical studies on chitosan-coated liposomes. Eur Biophys J38: 1127-1133.
29. Mu, L., Feng, S. S. (2002). The drug encapsulation ef?ciency, in vitro drug release, cellular uptake, and cytotoxicity of paclitaxelloaded poly(lactide)-tocopheryl polyethylene glycol succinate nanoparticles. J Contr Rel 80: 129.
30. Mu, L., Seow, P. H. (2006). Application of TPGS in polymeric nanoparticulate drug delivery system. Coll Surf B Biointerf 47: 90-97. (Pubitemid 43111610)
31. Mu, L., Elbayoumi, T. A., Torchilin, V. P. (2005). Mixed micelles made of poly(ethylene glycol)-phosphatidylethanolamine conjugate and d-?-tocopheryl polyethylene glycol 1000 succinate as pharmaceutical nanocarriers for camptothecin. Int J Pharm 306: 142.
32. Pan, M. H., Huang, T. M., Lin, J. K. (1999). Biotransformation of curcumin through reduction and glucuronidation in mice. Drug Metab Dispos 27: 486-494.
33. Patil, T. N., Srinivasan, M. (1971). Hypocholesteremic effect of curcumin in induced-hypercholesteremic rats. Indian J Exp Biol 9: 167-169.
34. Polnok, A., Borchard, G., Verhoef, J. C., Sarisuta, N., Junginger, H. E. (2004). Influence of methylation process on the degree of quaternization of N-trimethyl chitosan chloride. Eur J Pharm Biopharm 57: 77-83. (Pubitemid 38058805)
35. Prajakta, D., Ratnesh, J., Chandan, K., Suresh, S., Grace, S., Meera, V., et al. (2009). Curcumin loaded pH-sensitive nanoparticles for the treatment of colon cancer. J Biomed Nanotechnol 5: 445-455.
36. Ringman, J. M., Frautschy, S. A., Cole, G. M., Masterman, D. L., Cummings, J. L. (2005). A potential role of the curry spice curcumin in Alzheimer's disease. Curr Alzheimer Res 2: 131-136. (Pubitemid 40862872)
37. Ruby, A. J., Kuttan, G., Babu, K. D., Rajasekharan, K. N., Kuttan, R. (1995). Anti-tumor and antioxidant activity of natural curcuminoids. Cancer Lett 94: 79-83.
38. Setthacheewakul, S., Mahattanadul, S., Phadoongsombut, N., Pichayakorn, W., Wiwattanapatapee, R. (2010). Development and evaluation of self-microemulsifying liquid and pellet formulations of curcumin, and absorption studies in rats. Eur J Pharm Biopharm 76: 475-485.
39. Shaikh, J., Ankola, D. D., Beniwal, V., Singh, D., Ravi Kumar, M. N. V. (2009). Nanoparticle encapsulation improves oral bioavailability of curcumin by at least 9-fold when compared to curcumin administered with piperine as absorption enhancer. Eur J Pharm Sci 37: 223-230.
40. Shankar, T., Shantha, N., Ramesh, H., Murthy, I., Murthy V. (1980). Toxicity studies on turmeric (Curcuma longa): acute toxicity studies in rats, guinea pigs, and monkeys. Indian J Exp Biol 18: 73-75. (Pubitemid 10143537)
41. Sharma, R. A., Euden, S. A., Platton, S. L., Cooke, D. N., Shafayat, A., Hewitt, H. R., et al. (2004). Phase I clinical trial of oral curcumin: biomarkers of systemic activity and compliance. Clin Cancer Res 10: 6847-6854. (Pubitemid 39383033)
42. Shukla, P. K., Khanna, V. K., Ali, M. M., Khan, M. Y., Srimal, R. C. (2008). Anti-ischemic effect of curcumin in rat brain. Neurochem Res 33: 1036-1043.
43. Sieval, A. B., Thanou, M., Kotze, A. F., Verhoef, J. C., Brussee, J., Junginger, H. E. (1998). Preparation and NMR characterization of highly substituted IV-trimethyl chitosan chloride. Carbohydr Polym 36: 157-165. (Pubitemid 128399589)
44. Singh, B., Mehta, G., Kumar, R., Bhatia, A., Ahuja, N., Katare, O. P. (2005). Design, development, and optimization of nimesulideloaded liposomal systems for topical application. Curr Drug Deliv 2: 143-153. (Pubitemid 40488624)
45. Snyman, D., Hamman, J. H., Kotze, J. S., Rollings, J. E., Kotze, A. F. (2002). The relationship between the absolute molecular weight and the degree of quaternisation of N-trimethyl chitosan chloride. Carbohydr Polym 50: 145-150. (Pubitemid 34661462)
46. Sun, W. T., Zhang, N., Li, A. G., Zou, W. W., Xu, W. F. (2008). Preparation and evaluation of N3-O-toluyl-fluorouracil-loaded liposomes. Int J Pharm 353: 243-250.
47. Takeuchi, H., Matsui, Y., Sugihara, H., Yamamoto, H., Kawashima, Y. (2005). Effectiveness of submicron-sized, chitosan-coated liposomes in oral administration of peptide drugs. Int J Pharm 303: 160-170. (Pubitemid 41318033)
48. Takeuchi, H., Matsui, Y., Yamamoto, H., Kawashima, Y. (2003). Mucoadhesive properties of carbopol or chitisan-coated liposomes and their effectiveness in the oral administration of calcitonin to rats. Int J Pharm 86: 235-242. (Pubitemid 36084273)
49. Thanou, M., Florea, B. I., Langemeyer, M. W. E., Verhoef, J. C., Junginger, H. E. (2000b). N-trimethylated chitosan chloride (TMC) improves the intestinal permeation of the peptide drug buserelin in vitro (Caco-2 cells) and in vivo (rats). Pharm Res 17: 27-31. (Pubitemid 30121095)
50. Thanou, M., Kotze, A. F., Scharringhausen, T., Luesen, H. L., Boer, A. G., Verhoef, J. C., et al. (2000a). Effect of degree of quaternization of N-trimethyl chitosan chloride for enhanced transport of hydrophilic compounds across intestinal Caco-2 cell monolayers. J Contr Rel 64: 15-25. (Pubitemid 30035304)
51. Thanou, M., Verhoef, J. C., Junginger, H. E. (2001). Chitosan and its derivatives as intestinal absorption enhancers. Adv Drug Deliv Rev 50: 91-101.
52. Thanou, M., Verhoef, J. C., Marbach, P., Junginger, H. E. (2000c). Intestinal absorption of octreotide: N-trimethyl chitosan chloride (TMC) ameliorates the permeability and absorption properties of the somatostatin analogue in vitro and in vivo. J Pharm Sci 89: 951-957.
53. Thanou, M., Verhoef, J. C., Verheijden, J. H. M., Junginger, H. E. (2001). Intestinal absorption of octreotide using trimethyl chitosan chloride: studies in pigs. Pharm Res 18: 823-828. (Pubitemid 32783519)
54. Tonnesen, H. H., Ma'sson, M., Loftsson, T. (2002). Studies of curcumin and curcuminoids. XXVII. Cyclodextrin complexation: solubility, chemical, and photochemical stability. Int J Pharm 244: 127-135. (Pubitemid 35245453)
55. Torchilin, V. P. (2007). Targeted pharmaceutical nanocarriers for cancer therapy and imaging. AAPS J 9: 128-147.
56. Valero, V., Buzdar, A. U., Theriault, R. L., Azamia, N., Fonseca, G. A., Willey, J., et al. (1999). Phase II trial of liposome-encapsulated doxorubicin, cyclophosphamide, and fluoroutacil as first-line therapy in patients with metastatic breast cancer. J Clin Oncol 17: 1425-1434. (Pubitemid 29220848)
57. Vander Merwe, S. M., Verhoef, J. C., Kotze, A. F., Junginger, H. E. (2004). Trimethylated chitosan as polymeric absorption enhancer for improved peroral delivery of peptide drugs. Eur J Pharm Biopharm 58: 225-235. (Pubitemid 39037231)
58. Varma, M. V. S., Panchagnula, R. (2005). Enhanced oral paclitaxel absorption with vitamin E-TPGS: effect on solubility and permeability in vitro, in situ, and in vivo. Eur J Pharm Sci 25: 445-453. (Pubitemid 40853872)
59. Vasir, J. K., Tambwekar, K., Garg, S. (2003). Bioadhesive microspheres as a controlled drug delivery system. Int J Pharm 255: 13-32. (Pubitemid 36369587)
60. Venosa, G. D., Hermida, L., Batlle, A., Fukuda, H., Defain, M. V., Mamone, L., et al. (2008). Characterisation of liposomes containing aminolevulinic acid and derived esters. J Photochem Photobiol B 92: 1-9. (Pubitemid 351944030)
61. Venneman, N. G., Huisman, S. J., Moschetta, A., vanBerge Henegouwen, G. P., van Erpecum, K. J. (2002). Effects of hydrophobic and hydrophilic bile salt mixtures on cholesterol crystallisation in model biles. Biochim Biophys Acta 1583: 221-228. (Pubitemid 34765606)
62. Wang, J. L., Wang, R., Li, L. B. (2009b). Preparation and properties of hydroxycamptothecin-loaded nanoparticles made of amphiphilic copolymer and normal polymer. J Coll Interf Sci 336: 808-813.
63. Wang, S. X., Bao, A. B., Phillips, W. T., Goins, B., Herrera, S. J., Santoyo, C., et al. (2009a). Intraoperative therapy with liposomal drug delivery: retention and distribution in human head and neck squamous cell carcinoma xenograft model. Int J Pharm 373: 156-164.
64. Wang, Y. J., Pan, M. H., Cheng, A. L., Lin, L. I., Ho, C. Y., Hsieh, J. K., et al. (1997). Stability of curcumin in buffer solutions and characterization of its degradation products. J Pharm Biomed Anal 15: 1867-1876.
65. Win, K. Y., Feng, S. S. (2005). Effects of particle size and surface coating on cellular uptake of polymeric nanoparticles for oral delivery of anticancer drugs. Biomaterials 26: 2713-2722.
66. Win, K. Y., Feng, S. S. (2006). In vitro and in vivo studies on vitamin E TPGS-emulsi?ed poly(D,L-lactic-co-glycolic acid) nanoparticles for paclitaxel formulation. Biomaterials 27: 2285-2291. (Pubitemid 41774539)
67. Yang, K. Y., Lin, L. C., Tseng, T. Y., Wang, S. C., Tsai, T. H. (2007). Oral bioavailability of curcumin in rat and the herbal analysis from Curcuma longa by LC-MS/MS. J Chromatogr B Analyt Technol Biomed Life Sci 853: 183-189.
68. Ye, J.S., Wang, Q., Zhou, X. F., Zhang, N. (2008). Injectable actaritloaded solid lipid nanoparticles as passive targeting therapeutic agents for rheumatoid arthritis. Int J Pharm 352: 273-279. (Pubitemid 351273921)
69. Yu, L., Bridgers, A., Polli, J., Vickers, A. (1999). Vitamin E-TPGS increases absorption flux of an HIV protease inhibitor by enhancing its solubility and permeability. Pharm Res 16: 1812-1817. (Pubitemid 30040695)
70. Zambito, Y., Zaino, C., DiColo, G. (2006). Effects of N-trimethyl chitosan on transcellular and paracellular transcorneal drug transport. Eur J Pharm Biopharm 64: 16-25. (Pubitemid 44142234)
71. Zhai, G. X., Wu, J., Zhao, X., Yu, B., Li, H., Lu, Y., et al. (2008). Aliposomal delivery vehicle for the anticancer agent gossypol. Anticancer Res 28: 2801-2805.
72. Zhang, J. A., Anyarambhatla, G., Ma, L., Ugwu, S., Xuan, T., Sardone, T., et al. (2005). Development and charactrization of a novel Cremophor EL free liposome-based paclitaxel (LEP-ETU) formulation. Eur J Pharm Biopharm 59: 177-187. (Pubitemid 39573451)
73. Zhang, J., Wang, S. (2009). Topical use of coenzyme Q10-loaded liposomes coated with trimethyl chitosan: tolerance, precorneal retention, and anti-cataract effect. Int J Pharm 372: 66-75.
74. Zhu, W. W., Yu, A. H., Wang, W. H., Dong, R. Q., Wu, J., Zhai, G. X. (2008). Formulation design of microemulsion for dermal delivery of penciclovir. Int J Pharm 360: 184-190.